GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Price-to-Tangible-Book

Alto Neuroscience (Alto Neuroscience) Price-to-Tangible-Book : 1.80 (As of May. 26, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Price-to-Tangible-Book?

As of today (2024-05-26), Alto Neuroscience's share price is $12.92. Alto Neuroscience's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was $7.18. Hence, Alto Neuroscience's Price to Tangible Book Ratio of today is 1.80.

The historical rank and industry rank for Alto Neuroscience's Price-to-Tangible-Book or its related term are showing as below:

ANRO' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.8   Med: 2.14   Max: 2.14
Current: 1.8

During the past 3 years, Alto Neuroscience's highest Price to Tangible Book Ratio was 2.14. The lowest was 1.80. And the median was 2.14.

ANRO's Price-to-Tangible-Book is ranked better than
68.06% of 1221 companies
in the Biotechnology industry
Industry Median: 2.79 vs ANRO: 1.80

A closely related ratio is called PB Ratio. As of today, Alto Neuroscience's share price is $12.92. Alto Neuroscience's Book Value per Sharefor the quarter that ended in Mar. 2024 was $7.18. Hence, Alto Neuroscience's P/B Ratio of today is 1.80.


Alto Neuroscience Price-to-Tangible-Book Historical Data

The historical data trend for Alto Neuroscience's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Price-to-Tangible-Book Chart

Alto Neuroscience Annual Data
Trend Dec21 Dec22 Dec23
Price-to-Tangible-Book
- - -

Alto Neuroscience Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial - - - - 2.14

Competitive Comparison of Alto Neuroscience's Price-to-Tangible-Book

For the Biotechnology subindustry, Alto Neuroscience's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alto Neuroscience's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alto Neuroscience's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Alto Neuroscience's Price-to-Tangible-Book falls into.



Alto Neuroscience Price-to-Tangible-Book Calculation

Alto Neuroscience's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=12.92/7.183
=1.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Alto Neuroscience Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Alto Neuroscience (Alto Neuroscience) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Alto Neuroscience Inc is a clinical stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective treatment options. the company currently consists of five clinical-stage assets initially targeting major depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience (Alto Neuroscience) Headlines

From GuruFocus